Bisphosphonates Linked to Lower Breast Cancer Risk (CME/CE)

posted on Jun 22 by in the Uncategorized category The risk of invasive breast cancer declined 30% to 40% among postmenopausal women using bone-preserving bisphosphonate drugs, two large cohort studies have found.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes